Long-term treatment data for lecanemab to be presented at AAIC 2024
Go back to Long-term treatment data for lecanemab to be presented at AAIC 2024| BARNES GROUP, Inc. (NYSE: B) | Delayed: 38.63 -1.89 (4.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.52 | 52 Week High | $44.27 | |||
| Open | $39.60 | 52 Week Low | $30.07 | |||
| Day High | $39.79 | P/E | 29.49 | |||
| Day Low | $38.56 | EPS | $1.31 | |||
| Volume | 2,717,122 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 5.43 -0.14 (2.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $8.73 | |||
| Open | $5.49 | 52 Week Low | $2.86 | |||
| Day High | $5.58 | P/E | N/A | |||
| Day Low | $5.43 | EPS | $-3.82 | |||
| Volume | 104,482 | |||||



